AdaptHealth (AHCO) Cash & Equivalents Growth (3y) (2020 - 2026)
AdaptHealth (AHCO) Cash & Equivalents Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 32.23% |
| 10 | AdaptHealth | 741.17 Mn | 697.88 Mn | 104.21 Mn | -1.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.38% |
| Mar 31, 2026 | -22.08% |
| Dec 31, 2025 | 31.88% |
| Sep 30, 2025 | -10.14% |
| Jun 30, 2025 | -16.72% |
| Mar 31, 2025 | -23.41% |
| Dec 31, 2024 | -9.82% |
| Sep 30, 2024 | -33.24% |
| Jun 30, 2024 | -26.82% |
| Mar 31, 2024 | -15.56% |
| Dec 31, 2023 | -8.28% |
| Sep 30, 2023 | -40.92% |
| Jun 30, 2023 | -25.83% |
| Mar 31, 2023 | 28.17% |
| Dec 31, 2022 | -15.57% |
| Sep 30, 2022 | 132.40% |
| Jun 30, 2022 | 280.36% |
| Mar 31, 2022 | 100.26% |
| Dec 31, 2021 | 81.11% |
| Sep 30, 2021 | 635.33% |